Name: Marker Therapeutics, Inc. (MRKR) Balance Sheet
Creator: FinSpry

Marker Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Marker Therapeutics, Inc. (MRKR) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Current Assets
Cash and Cash Equivalents	19.19	15.10	11.78	42.35	21.35	43.90
Cash & Short-Term Investments	19.19	15.10	11.78	42.35	21.35	43.90
Accounts Receivable	2.35	1.03	2.40	0.00	1.00	0.06
Inventory	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.48	0.99	1.85	2.48	2.06	0.00
Total Current Assets	22.02	17.13	16.62	45.98	24.41	45.49
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.00	17.82	22.15	21.20	0.87
Other Non-Current Assets	0.00	0.00	17.80	0.00	0.00	0.00
Total Non-Current Assets	0.00	0.00	17.80	22.15	21.20	0.87
Total Assets	22.02	17.13	34.42	68.14	45.61	46.36
Current Liabilities
Accounts Payable	1.07	1.75	1.10	5.14	6.01	1.76
Accrued Liabilities	0.50	1.91	1.27	3.33	2.95	0.00
Deferred Revenue	0.00	0.00	2.50	1.15	0.00	0.00
Other Current Liabilities	2.29	1.33	5.41	2.66	1.69	0.03
Total Current Liabilities	3.46	3.07	7.78	12.90	6.40	1.99
Non-Current Liabilities
Long-Term Debt	0.00	0.00	7.04	11.25	11.87	0.28
Other Non-Current Liabilities	0.00	0.00	7.04	0.00	0.00	0.00
Total Non-Current Liabilities	0.00	0.00	7.04	11.25	11.87	0.28
Total Liabilities	3.46	3.07	14.82	24.15	18.27	2.27
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.05	0.00
Retained Earnings	-447.02	-436.29	-428.05	-398.12	-356.24	-327.53
Additional Paid-in Capital	465.56	450.33	447.64	442.10	383.53	371.57
Shares Outstanding	10.71	8.90	8.40	8.31	0.00	0.00
Total Stockholders' Equity	18.56	14.05	19.60	43.99	27.34	44.09
Total Liabilities & Equity	22.02	17.13	34.42	68.14	45.61	46.36